Bausch + Lomb Reports Strong Q2 Performance Despite Product RecallBausch + Lomb Corporation reported strong Q2 2025 results, with revenue growth of 5% and adjusted EBITDA of $191 million, despite facing a product recall.Bausch + Lomb Corp Health Care Health Care Equipment & Services AI generated 2025-07-30 3 minutes to read
